Registrations have closed.
3rd International Cannabinoid Derived Pharmaceuticals Summit
by
102 102 people viewed this event.
In a year that saw a significant rise in the clinical pipeline of cannabis-derived therapeutics and the worldwide sales of Epidiolex soar, this Summit is back to facilitate continued growth in the cannabinoid pharmaceuticals sector.
Additional Details
Etkinlik Ülkesi - Other
